SCHEMBL4768211

SCHEMBL4768211

CS(=O)(=O)N(Cc1ccccc1C#N)c1ccc(N(C=O)Cc2ccc(C(F)(F)F)nc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.36
HDAC6 Q9UBN7 2/20 0.35
TAS2R14 Q9NYV8 2/20 0.34
P2RX3 P56373 1/20 0.33
P2RX2 Q9UBL9 1/20 0.33
PGR P06401 1/20 0.33
CYP2C9 P11712 1/20 0.33
GRM2 Q14416 2/20 0.32
KCNH2 Q12809 1/20 0.32
NR3C1 P04150 1/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32
RORC P51449 1/20 0.32
RECQL P46063 1/20 0.31
P2RX7 Q99572 1/20 0.31
ALDH1A1 P00352 1/20 0.31
AGTR1 P30556 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4771247 0.87 ALDH1A1 (0.42) TRPM8HDAC6GRM2POLBRECQL
SCHEMBL4768261 0.87 TRPM8 (0.38) TRPM8HDAC6CYP2C9GRM2KCNH2
SCHEMBL5571164 0.86 GAA (0.44) TRPM8HDAC6GRM2KCNH2POLB
SCHEMBL4772997 0.85 TRPM8 (0.39) TRPM8HDAC6ALDH1A1
SCHEMBL4773365 0.84 LMNA (0.36) HDAC6GRM2GAARECQLALDH1A1
SCHEMBL4776872 0.84 RECQL (0.39) HDAC6GRM2KCNH2POLBRECQL
SCHEMBL4776637 0.83 RECQL (0.36) TRPM8HDAC6POLBRECQLALDH1A1
SCHEMBL4772347 0.83 GAA (0.37) TRPM8HDAC6KCNH2POLBGAA
SCHEMBL4772420 0.82 GAA (0.37) TRPM8HDAC6POLBGAARECQL
SCHEMBL4770843 0.82 LMNA (0.36) HDAC6KCNH2POLBGAARORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US claimed
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP disclosed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US disclosed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135435-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 TRPM8 3499/4885HDAC6 137/4885TAS2R14 4878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.